Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study
| Image |  |
|---|---|
| Description | scientific article published in March 2005 |
| Author/s |
author: Heinz-Josef Lenz David Scott Miller |
| Publication date | March 1, 2005 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |